Cargando…
Re: ‘Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review’ by Serafim et al.
Autores principales: | Lipes, Jed, Yang, Stephen Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826130/ https://www.ncbi.nlm.nih.gov/pubmed/33484842 http://dx.doi.org/10.1016/j.cmi.2021.01.010 |
Ejemplares similares
-
Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series
por: Yang, Stephen Su, et al.
Publicado: (2021) -
Re: ‘Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review - authors' reply’
por: Serafim, Rodrigo B., et al.
Publicado: (2021) -
2016 ISCB Innovator Award: Serafim Batzoglou
por: Fogg, Christiana N., et al.
Publicado: (2016) -
Re: “High prevalence of heterotopic ossification in critically ill patients with severe COVID-19” by Stoira et al.
por: de l’Escalopier, Nicolas, et al.
Publicado: (2021) -
Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)